News

Published on 30 Nov 2021 on Benzinga

Longeveron Announces Clinical Collaboration To Study Cell Therapy Aging Treatment In Japan: Why It...


Article preview image

Longeveron Inc. (NASDAQ: LGVN) announced Friday a clinical trial collaboration to study its lead investigational asset, Lomecel-B.

What Happened: Florida-based Longeverson said it has entered into a sponsored clinical research agreement with Japan's National Center for Geriatrics and Gerontology and the Juntendo University Hospital to study Lomcecel-B in older, frail Japanese subjects.

NASDAQ.LGVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday’s...

Shares of The Travelers Companies, Inc. TRV fell sharply during Wednesday’s session following fi...

Benzinga 17 Apr 2024

Longeveron to raise $6.2 million through warrant exercises By Investing.com

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company, announced today that it h...

Investing.com 17 Apr 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65% By Investing.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65%

Investing.com 15 Apr 2024

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In...

Shares of Ultragenyx Pharmaceutical Inc. RARE fell sharply during Monday’s session after the co...

Benzinga 15 Apr 2024

Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings -Longeveron (NASDAQ:LGVN), Goldman...

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on ...

Benzinga 15 Apr 2024

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving...

Shares of Medical Properties Trust, Inc. MPW rose sharply in today’s pre-market trading after th...

Benzinga 15 Apr 2024

Chief Scientific Officer Joshua Hare Acquires 148,936 Shares of Longeveron Inc (LGVN)

Longeveron Inc (NASDAQ:LGVN), a biotechnology company specializing in the development of cellular...

GuruFocus.com via Yahoo Finance 12 Apr 2024

Longeveron director buys $325,000 in company stock By Investing.com

Longeveron Inc. (NASDAQ:LGVN) director Soffer Rock has recently made significant purchases of the...

Investing.com 12 Apr 2024

Longeveron CEO buys $25k in company stock

Longeveron Inc. (NASDAQ:LGVN) CEO Hashad Mohamed Wa'el Ahmed acquired additional shares in the co...

Investing.com 11 Apr 2024

US Stocks Higher; Dow Gains Over 50 Points - Ducommun (NYSE:DCO), Auddia (NASDAQ:AUUD)

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Monday...

Benzinga 8 Apr 2024